Monday, 11 December 2017

Urology Surgical Instruments Market, By Product Type, Distribution Channel, and Application - Global Trends, and Forecast 2017 - 2025

Urology surgeries are associated with the treatment of urologic disease or dysfunction of male and female urinary tract. Urologic disease or dysfunction in male include bladder control dysfunction, kidney stones, prostate disorders, nephrectomy, pyeloplasty, ureteral reimplants, and urinary retention. According to the National Kidney Foundation (NKF), in 2016, around 121,678 people were waiting for organ transplants in the U.S., out of which 100,791 were waiting for kidney transplants. According to National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), overall prevalence of chronic kidney disease in the U.S. was around 14% in 2016.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1036

The growth of urology surgical instruments market is backed by the rising prevalence of urinary tract infections, kidney diseases, and increasing geriatric population, which opt for the surgical urology procedures. According to the United States Renal data System (USRDS), between 2012 and 2013, there was 3.1% increase in the cumulative number of recipients with kidney transplant. According to the NKF, around 17,107 kidney transplants took place in the U.S. in 2014, moreover approximately 3,000 new patients are added to kidney transplant waiting list each month. According to the National Chronic Kidney Disease 2017 Factsheet, estimated by Centers for Disease Control and Prevention (CDC), around 15% or 30 million geriatric population in the U.S. are reported to have chronic kidney disease (CKD), out of which around 48% people are suffering from severely impaired kidney function. Increased number of geriatric population with diabetics, high blood pressure or people having both are at higher risk of developing CKD, which further may lead to kidney transplant surgery, in turn driving the urology surgical instruments market. According to the CDC, in 2017, approximately 1 in 3 adults having diabetes condition in the U.S., may have any of the chronic kidney disorder.

However, high risk of complications associated with surgical procedures in geriatric patients and increasing cost of urology endoscope and laparoscopic endovision system, are expected to be major restraints for the urology surgical instruments market. According to the data published in National Center for Biotechnology Information (NCBI), U.S. National Library of Medicine, in February 2015, number of geriatric population undergoing urological surgeries showed various surgical complicated infections such as sepsis, mild respiratory insufficiency, and delirium.

Urology Surgical Instruments Market Taxonomy:

On the basis of product type, the global urology surgical instruments market segmented into:
  • Cysto sheaths
  • Urology endoscope
  • Cystoscope
    • Laser cystoscope
    • Rigid cystoscope
    • Flexible cystoscope
  • Resectoscope
  • Nephroscope
  • Pediatric nephroscope
  • Ureteroscope
  • Flexible ureteroscope
  • Rigid ureteroscope
  • Laparoscope
  • Forceps
  • Optical forceps
  • Flexible forceps
  • Resectoscope electrodes
  • Urethrotome
  • Cystoscope bridge
  • Channel deflector
  • Other urology accessories
On the basis of distribution channel, the global urology surgical instruments market segmented into:
  • Hospitals
  • Surgical Centers
On the basis of application, the global urology surgical instruments market segmented into:
  • Kidney stone
  • Urinary tract infections
  • Urinary bladder disorder
  • Chronic kidney disease
  • Benign prostatic hyperplasia
  • Other applications
Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/urology-surgical-instruments-market-1036

Continuous development in robotic-assisted surgeries to drive the market growth

Minimally invasive robotic-assisted surgeries are found to be effective in treating various urological disease and dysfunction, which include kidney cancer, prostate cancer, kidney dysfunction, urinary tract disorders, and congenital abnormalities in children. Loyola medicine, an academic medical center of Loyola University Health System, in 2017, developed a RoboLog, a web-based robotic experience logging system, which records surgical process progression, experience, and provides feedback during robotic assisted surgery. According to the study published in Journal of Surgical Education 2017, RoboLog, was successfully completed and piloted on 310 urologic robotic surgeries. RoboLog developed a reporting structure where surgeon can view statistics like log time and median time for each step involved in robotic surgery.

Titan Medical Inc. in 2017, announced the successful completion of world’s first gynecologic, urological, and colorectal single port robotic procedures, which was performed using advanced prototype named, SPORT Surgical System at Florida Hospital Nicholson Center. Titan Medical Inc. is engaged in the design, development, and commercialization of robotic surgical procedures for application in minimally invasive surgery. Single-port surgery is minimally invasive surgery performed through a single port or incision. Although it is difficult without robotic assistance, it is highly beneficial, due to involvement of fewer ports, low complications, and rapid recovery. Moreover SPORT Surgical System is employed with capabilities to become valuable tool for robotic surgeons to perform single port surgery.

Such advancement in robotic assisted surgery enables the surgeons to perform complex operation in more precise way than conventional surgery, adding to the benefits such as, less blood loss, significantly less pain, lower risk of infection, shorter hospital stay, low recovery time, and better clinical outcome, which is expected to drive the growth of urology surgical instruments market in near future.

Some of the key players operating in the urology surgical instruments market includes Millennium Surgical Corp, Maxer Medizintechnik GmbH, Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Teleflex Incorporated, Richard Wolf GmbH, Coloplast A/S, CONMED Corporation, STRYKER CORPORATION, CooperSurgical Inc., and COOK MEDICAL LLC.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Wednesday, 6 December 2017

Endoscopy Device Market, By Product Type, End User - Industry Insights, Trends, Outlook and Opportunity Analysis, 2025

Endoscopy devices are minimally-invasive diagnostic medical devices used to assess the internal organs of the body. Endoscopy devices are used to investigate unusual symptoms and perform certain types of surgery. An endoscopy device has a flexible tube with an attached camera, which allows the doctor to view potential threats without a large incision. Therapeutic endoscopy devices are modified endoscopes with surgical instruments attached to them to carry surgeries to remove kidney stones, fibroids. The simplicity of the procedure with minimal post operation complications makes it the most preferred and pursued procedure in surgery and diagnostics. The diverse applications of endoscopes to diagnose and treat various diseases has increased the adoption of flexible endoscopes across different healthcare settings. These devices include operative devices and visualization systems, which gives direct insight of the organs for efficient treatment, unlike other medical imaging devices.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/442

Increasing prevalence of chronic diseases in the elderly population will boost the endoscopy device market

According to the World Health Organization in 2011, the world's population aged 60 years will double from 11% in 2000 to 22% by 2050. A central factor that boosts the endoscopy device market is the increase in number of elderly people prone to cancer, orthopedic, ophthalmic gastrointestinal diseases. With the constant increase in the elderly people, age-linked ailments are expected to escalate sharply, thus driving the demand and consumption of endoscopy devices. Also, endoscopy assures low-risk procedures and are easily covered by health insurance. Additionally, high prevalence of diseases requiring endoscopy for diagnosis and treatment, rising geriatric population, technological advancements, FDA approvals, reimbursement policies are the other factors driving the endoscopy device market.

Visualization systems segment holds the lion share in the endoscopy device market

The global endoscopy device market is segmented on the basis of product type, applications, end user and geography.

On the basis of product type, the global endoscopy equipment market is segmented into:
  • Endoscopes
  • Rigid Endoscopes
  • Flexible Endoscopes
  • Capsule Endoscopes
  • Surgical Endoscopes
  • Robot-assisted Endoscopes
On the basis of applications, global endoscopy equipment market is segmented into:
  • Gastrointestinal Endoscopy
  • Gynecology Endoscopy
  • Urology Endoscopy
  • Bronchoscopy
  • Laryngoscopy
  • Neuroendoscopy
  • Others
On the basis of end user, global endoscopy equipment market is segmented into:
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Others
The advanced 3D imaging gives depth perception and is expected to dominate North Americanendoscopy equipment market

Regional segmentation of the global endoscopy equipment market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. According to the World Journal of Gastrointestinal Endoscopy in 2016, 7 million people in the U.S. have symptoms of Gastroesophageal Reflux Disorder (GERD) and is expected to reach around 9 million by 2025. North America has therefore dominated the global endoscopy equipment market with the increasing prevalence of diseases and approved government grants.  Europe is likely to witness surging demand as a result of rapidly aging population, increased obesity rates, growing incidence of associated disease technological advancements and improved reimbursement status. According to the Journal of Neurogastroenterology in 2011, the prevalence of endoscopic reflux esophagitis in East Asia was 6% in 2005 which has increased to 15% in 2015. Therefore, increasing affluence and number of private hospitals, expansion to rural healthcare facilities play an important role in boosting the demand in China and India in the Asian market.


Robot-assisted endoscopic devices are expected to increase in demand in the future

The key players in the global endoscopic devices market include Artherx Inc., Boston Scientific Corporation, Conmed Corporation. Covidien has the largest market for capsule endoscopy due to the increased preference amongst physicians globally. Other vendors include Olympus Corporation, Ethicon, Karl Storz GmbH, Fujifilm Holding Corporation, Richard Wolf GmbH.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Tuesday, 5 December 2017

Anesthesia Machines Market, By Product Type, End User - Industry Insights, Trends, Outlook and Opportunity Analysis, 2025

Anesthesia is a practice of controlling the pain or other sensation during the time of surgery and other procedures with or without the loss of consciousness. It also helps in controlling the breathing, blood flow, blood pressure, and heart rate and rhythm.  There are four different types of anesthesia that includes local, general, regional and dissociative. Anesthesia machines are used by the professionals to support the administration of anesthesia. These machines deliver precisely known but variable gas mixtures, which are then delivered to the breathing systems. These gases are administered with the help of oxygen mask. Patients are administered a mixture of oxygen, nitrous oxide and other gases that are regulated by anesthetic machines. Over the years, anesthesia machines have evolved from a simple pneumatic device to a complex array of electrical, mechanical and computer controlled systems for patient safety and user convenience.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/432

The anesthetic machine comprises three pressure systems:
  • A high pressure system that collects gases at cylinder pressure
  • An intermediate pressure system that delivers gases to flow meters.
  • A low pressure system that carries gases from the flow meters to the machine outlet
The advanced anesthetic machines comprise of better features compared to conventional machines in terms of proper ventilation techniques, accurate monitoring features, inhaled agent delivery, low flow and closed loop anesthesia.

Latest machines launched in 2015 and 2016, in the global anesthesia machines market, such as the Venor Xenon workstation (Chirana Medical), Felix Dual (Air Liquide Medical system) and Tangens 2C (EKU Electronics), have the advanced features to recycle and reuse xenon, making it cost effective and helping professionals to use xenon based anesthesia simultaneously with conventional nitrous oxide based anesthesia.

Anesthesia machines market taxonomy:

On the basis of technology, the anesthesia machines market is classified into:
  • Intermittent
  • Continuous
The continuous type anesthetic machines are majorly used in the market as they allow gas flow during inspiration and expiration.

On the basis of product type, the anesthesia machines market is classified into:
  • Portable Anesthesia Machines
  • Stand Alone Anesthesia Machines
On the basis of end user, the market is classified into:
  • Hospitals
  • Clinic
  • Ambulatory Surgical Centers
Geriatric population is highly susceptible to diseases and thus, account for a large proportion of the global patient population. According to United Nations, Department of Economic and Social Affairs, Population Division,  the global population aged 60 & above increased by 68% in urban areas and by 25% in the rural areas between 2000 and 2015. This rise in geriatric population scenario is shaping favorably for sustained growth of anesthesia machines market over the following decade. Furthermore, the rise in surgical procedures and increasing accident and trauma cases serve as the driving factor for the growth of the market. According to World Health Organization, around 266.2 to 359.5 million surgeries were performed in 2012, which represents a 38% increase over the previous 8 years.

The continuous improvements in healthcare sector and adoption of minimal invasive surgeries are favoring the growth of anesthesia machines market.  By geography, North America holds the major share due to advanced healthcare infrastructure and is followed by Europe and Asia Pacific, respectively. According to a study published in NCBI in 2014, there has been a significant increase of 31.3% in minimal invasive surgical procedures from 2007 to 2012.  Among Asian countries, China and India are shown to experience a considerable market growth due to the large patient pool and increasing number of hospitals. As per Association for Safe International Road Travel (ASIRT), over 90% of the total road accidents occurs in low and middle-income countries.


However, high cost of the anesthetic machines is one of the barrier to this market. Also, there exists a refurbished and used market for anesthetic machines which can serve as a restraining factor for the global anesthesia machines market.

Major players in the anesthesia machines market are Smiths medical, GE Healthcare, Spacelabs Healthcare, Covidien, Dragerwerk, Aeonmed, Heyer Medical, Oricare, Oricare, Supera Anesthesia Innovations, Dameca A•S, Carefusion Corporation and KGaA, Getinge Group.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Thursday, 30 November 2017

Vascular Grafts Market, By Product Type, End User - Industry Insights, Trends, Outlook and Opportunity Analysis, 2025

Vascular Grafts are medical devices used to bypass the infected or diseased blood vessels. Vascular grafts are required to replace injured blood vessels, veins, and arteries and to substitute hard blood vessels or valves. Blood flow is redirected from one place to another by introducing a graft with the help of surgical reconstruction process. These grafts can be synthetic, semi-synthetic or taken from the patient’s body.

Vascular grafts are majorly used in treatment of cardiovascular diseases by surgical procedures such as bypass grafting. The graft is taken from the patient’s body and surgically inserted at the required site to bypass the damaged or diseased blood vessels. Factors such as smoking, high blood pressure, atherosclerosis, and diabetes lead to chronic heart diseases in turn increasing the demand for effective and life sustaining treatment. Bypass surgeries are performed in patients suffering from coronary artery diseases, angina pectoris, heart attack, atherosclerosis, diabetes, and multiple heart artery blockages.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1075

Rising prevalence of coronary artery diseases is expected to boost the growth of vascular grafts market

According to Centers for Disease Control and Prevention (CDC) in 2016, approximately 8.5 million people in the U.S. had peripheral arterial diseases with healthcare costs accounting for US$ 21 billion annually. Increasing requirement for treatment with bypass surgeries is expected to boost the growth of vascular grafts market.

Age is also a risk factor for coronary artery diseases. In 2015, around 44 million people over age 60 were suffering from coronary artery diseases in the U.S. according to American Heart Association (AHA). Furthermore, according to the AHA in 2017, around 92 million American adults are suffering from cardiovascular diseases, which is expected to fuel the growth of vascular grafts market.

According to National Health Service (NHS) in England, around 20,000 coronary bypass surgeries are carried out annually, which is expected to rise due to changing lifestyle habits leading to chronic cardiovascular diseases, in turn rising demand for the treatment.

Factors such as increasing geriatric population, increasing diabetes prevalence leading to heart diseases, and unhealthy lifestyles are expected to increase the prevalence of cardiovascular diseases, in turn boosting the growth of bypass surgeries and vascular grafts market. Complications in the bypass surgery such as bleeding, arrhythmias and stroke are the restraining factors for the market.

Vascular Grafts Market Taxonomy

Advancements in graft materials and surgery techniques such as off-pump CABG surgery are driving the growth of vascular grafts market. The global vascular grafts market is segmented on the basis of product type, application, material, end user, and geography.

On the basis of product type, the global vascular grafts market is segmented into:
  • Endovascular Stent Graft
  • Hemodialysis Access Graft
  • Bypass Graft
  • Peripheral Vascular Graft
  • Others
On the basis of application, the global vascular grafts market is segmented into:
  • Coronary Artery Disease
  • Vascular Occlusion
  • Renal Failure
  • Aneurysm
  • Others
On the basis of material, the global vascular grafts market is segmented into:
  • Synthetic
  • Teflon
  • Nylon
  • Dacron
  • Others
  • Biological
  • Bovine Vein
  • Saphenous Vein
  • Others
  • Biosynthetic
  • Ovine Collagen with Polyester
  • Others
On the basis of end user, the global vascular grafts market is segmented into:
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others

Regional segmentation of the vascular grafts market by Coherent Market Insights comprises North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America region is expected to dominate the market due to increasing prevalence of lifestyle diseases especially cardiovascular disease, skilled medical professionals coupled with insurance facilities, and increasing geriatric population, which is at a high risk of cardiovascular diseases. Asia Pacific region is expected to show the highest growth rate in the market during the forecast period due to factors such as improving healthcare facilities, increasing awareness towards heart diseases, and increasing diabetes prevalence. In India vascular grafts market is expected to show highest growth rate due to factors such as large customer base, rising awareness through government programs such as World Heart Day, and increasing life expectancy. In 2015, around 30 million people were suffering from cardiovascular diseases in India and the number is expected to increase over the forecast period.

Key players operating in the vascular grafts market include Medtronic Plc., Vascutek Ltd, W.L. Gore & Associates, Inc., B. Braun Melsungen AG, Terumo Medical Corporation, Artegraft, Bard Peripheral Vascular Inc., LeMaitre Vascular Inc., and Heart Medical Europe BV.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Friday, 24 November 2017

Pressure Bandages Market, By Product, Technology, and End User - Opportunity Analysis, 2025

Leg ulcer is one of the most common ailments among the adult population. It is a fault in the skin of the lower portion of the leg with slow or no healing propensity of a wound over a period of 3 months. Simply put, a leg ulcer is a rupture in the leg skin, which permits bacteria and air to permeate into the fundamental or underlying tissue. Leg ulcers are usually caused by injury that breaks the skin.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/228

The management of chronic leg ulceration include a variety of compression therapies such as garments such as bandages and stockings and intermittent pneumatic. Pressure bandages falls under the category of compression garment that aids in faster healing and controlling infection of wounds, while prevention of excessive blood loss as well. Compression bandages also called pressure bandages, are a kind of field dressing used to apply pressure to a wound. These are usually wrapped around the wound and are then pulled tight to maximize the pressure applied in the area. Pressure bandages are usually used in situations where instantaneous first aid is necessary to protect one’s health. They are wrapped around the lower limb to apply a desired pressure that offers a degree of firmness directly to the wound. Pressure bandages are predominantly used for treating venous leg ulcers, swelling, oedema, sprains, and other lymphatic conditions.

One of the important factors is to apply the pressure bandage carefully or else it can lead to a several complications such as tourniquet negative effect and decrease blood pressure. The primary symptoms of leg ulcer are friable granulation, cramps in the calves, skin discolorations and dermatitis. Around 2 to 3 million people in the U.S. are identified with chronic wounds each year, according to the Wound Healing Society (a scientific group focused on wound healing). The rising prevalence of chronic leg ulcer will lead to an increase in demand for pressure bandages during the forecast period.

Pressure Bandages market Taxonomy

On the basis of product type, the global market is classified into:
  • Long Stretch or Elastic Bandages
  • Multi-component Multilayer Bandage Systems (MLBs)
  • Short Stretch or Low-elasticity Bandages
On the basis of raw material, the global market is classified into:
  • Cotton Fabric
  • Latex
  • Polymer
  • Fiber
The elastic or long stretch bandages held a significant market share in the global pressure bandages market. High elasticity of over 100% and its high extensibility that can apply constant pressure to the wound directly, are some of the factors responsible for the dominance of the segment in the global pressure bandages industry. These pressure bandages are usually recommended for stationary patients who are incapable of activating their calf-muscle pump. Multi-component multilayer bandages act as an alternative to long elastic pressure bandages. They deliver constant and consistent compression for managing lower leg ulcers.

Growing prevalence of chronic leg ulcer and increase in the geriatric population will drive the overall pressure bandages market

An independent study available in Hindawi Publishing Corporation (a commercial publisher of technical, scientific, and medical literature) revealed that 1% of the overall adult population suffers from chronic leg ulceration and it affects 3.5% of people older than 65 years. North America accounted for the maximum share in the global pressure bandages market, followed by Asia Pacific. This is mainly attributed to high prevalence of chronic leg ulcers, presence of large number of manufacturers of pressure bandages, developed healthcare facilities, and increase in research related activities.


The emerging economies of India and China in Asia Pacific hold enormous potential for growth of the market due to the presence of large elderly population, considerable growth in private & public hospitals and drug stores, growing per capita income coupled with growth in healthcare expenditure. This region is expected to grow at a maximum rate in the global pressure bandages market over the course of the forecast period.

Some of the companies operating in the pressure bandages market in the current scenario are BSN medical, 3M, Johnson & Johnson, Lohmann & Rauscher, Smith & Nephew, and Covidien. Some of the other companies operating in the market are Datt Mediproducts Private Limited, Moore Medical LLC, Mölnlycke Health Care, Dynamic Techno Medicals and Paul Hartmann Pty. Ltd.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Tuesday, 14 November 2017

Endoscope Reprocessing Device Market, By Product, Technology, and End User - Opportunity Analysis, 2025

Endoscope reprocessing devices are used in the healthcare settings for the reprocessing procedures of the endoscopes. The endoscope reprocessing devices are used to decontaminate the instruments and devices such as duodenoscopes, endoscope accessories, and others. Endoscope reprocessing devices are Class II devices cleared through the premarket notification by the Food and Drug Administration (FDA). The devices are designed to inhibit microorganisms in or on reusable endoscopes by exposing their outside surfaces and interior channels to chemical solutions. Moreover, the endoscope reprocessing devices reduce staff exposure hazards associated with aldehyde-based solutions, thus granting major safety advantage for the adoption and usage of endoscope reprocessing devices.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1010

Rising adoption of the innovative automated endoscope reprocessors in the healthcare settings to augment the growth of endoscope reprocessing market

The rise in adoption of endoscope reprocessors in hospitals for infection prevention and control and the emergence of automated endoscope reprocessors (AER) in the healthcare settings is expected to fuel the growth of the global endoscope reprocessing device market over the forecast period. The AERs can enhance the reliability and consistency of endoscope reprocessing by standardizing several important reprocessing steps, thereby reducing the possibility of human error. The use of AERs reduces exposure of personnel to harmful chemical germicides, thereby minimizing the health problems attributed to reprocessing of endoscopes. Moreover, rising government concerns pertaining to patient safety and strong healthcare infrastructure support are the factors contributing to rise in global endoscope reprocessing device market. For instance, in 2015, the Centers for Disease Control and Prevention (CDC) has asked the Healthcare Infection Control Practices Advisory Committee (HICPAC) to issue guidelines for the improvement of facility-level training to ensure competency for endoscope reprocessing devices.

However, higher cost associated with the chemicals and consumables, infection risks after endoscopic reprocessing procedures, and complications associated with automated endoscope reprocessors are some of the factors restraining the growth of the global endoscope reprocessing market.

Global Endoscope Reprocessing Device Market Taxonomy

The global endoscope reprocessing device market is segmented on the basis of product type, modality, end user, and geography.

On the basis of product type, the global endoscope reprocessing device market is segmented into:
  • Ultrasonic washers
  • Pasteurizers
  • Washer-disinfectors
  • Sterilizers
  • Automated endoscope reprocessors (AERs)
  • Single basin automated endoscopic reprocessors
  • Double basin automated endoscopic reprocessors
On the basis of modality, the global endoscope reprocessing device market is segmented into:
  • Stand- alone endoscopic reprocessors
  • Bench top endoscopic reprocessors
On the basis of end user, the global endoscope reprocessing device market is segmented into:
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
Rising number of endoscopic procedures in North America is expected to dominate the endoscope reprocessing devices market

Regional segmentation of the endoscope reprocessing device market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to dominate the endoscope reprocessing device market with the factors attributed to larger number of endoscopic procedures. According to the American Society for Gastrointestinal Endoscopy, 2016, approximately 20 million gastro intestinal endoscopic procedures are performed annually in the U.S. with the transmission rate of infectious agents with an estimated frequency of 1 out of 1.8 million procedures. Asia Pacific is expected to witness a drastic growth in global endoscope reprocessing device market, owing to the enhanced competition with the presence of top manufacturers and ageing population susceptible to frequent medical check-ups, thus creating a positive impact on the endoscope reprocessing devices market.


Launch of innovative automated reprocessing devices by the major players to accelerate the global endoscope reprocessing device market

The key players operating the endoscope reprocessing device market are STERIS Plc., Cilag GmbH International, Soluscope, ENDO-TECHNIK W.Griesat GmbH, Getinge AB, PENTAX Medical, Wassenburg Medical B.V., Steelco S.p.A., Medivators Inc., Johnson & Johnson, and Minntech Corp. The key players are mainly focused on product innovations and global expansion of the products to expand the market presence. For instance, the Getinge ED-FLOW AER (automated endoscope reprocessing) launched by Getinge Group in 2014, is the world's first true pass-through AER. The product two separate chambers and short cycles, which offers excellent capacity to reprocess 6 endoscopes per hour, providing solutions in large endoscopy departments.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Monday, 13 November 2017

Laboratory Filtration in Health Care Market, By Product, Technology, and End User - Opportunity Analysis, 2025

Filtration has a wide laboratory-scale applications as it is used in various fields, such as research laboratories, microbial analysis, discovery and development of drugs and vaccines, and virus removal. Laboratory filtration is used in sample preparation prior to the analysis by using an instrumental analytical method such HPLC/UHPLC. Laboratory filtration is also used in instrument protection. For instance, hydrophobic filter in the pipette. Furthermore, analytical filtration are used in water quality testing to determine the microbial content of samples. Considering the wide application for laboratory filtration products, increase in the usage of analytical instruments, and introduction of advance filters is expected to drive the growth of laboratory filtration in healthcare market during the forecast period.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1015

Global Laboratory Filtration in Healthcare Market Taxonomy

The global laboratory filtration in healthcare market is segmented on the basis of product, technology, and end user

By Product
  • Filtration Assemblies
    • Microfiltration Assemblies
    • Reverse Osmosis Assemblies
    • Ultrafiltration Assemblies
    • Vacuum Filtration Assemblies
    • Others
  • Filtration Media
  • Filter Papers
  • Cellulose Filter Papers
  • Glass Microfiber Filter Papers
  • Quartz Filter Papers
  • Membrane Filters
  • Syringe Filters
  • Syringeless Filters
  • Capsule Filters
  • Filtration Microplates
  • Others
  • Filtration Accessories
    • Filter Holders
    • Filter Funnels
    • Filter Dispensers
    • Filter Flasks
    • Filter Housings
    • Cartridges
    • Vacuum Pumps
    • Seals
    • Other Accessories
By Technology:
  • Microfiltration
  • Ultrafiltration
  • Reverse Osmosis
  • Vacuum Filtration
  • Nano filtration
By End User:
  • Pharmaceutical & Biopharmaceutical Companies
  • Academic & Research Institutes
  • Hospital & Diagnostic Laboratories

Technological advancement is expected to boost the growth of the laboratory filtration in healthcare market

The laboratory filtration market has witnessed new product launches and innovative technologies. The technological advanced product provides high reliability and throughput as compared to conventional methods. For instance, Merck KGaA Durapore 0.22 µm hydrophilic Polyvinylidene fluoride (PVDF) membranes is used in endotoxins removal and is designed for sterile filtration. Durapore also provides high protein recovery with minimal loss of valuable product. Durapore is also used for filtration of lipids in small and large volume system. Reverse Osmosis systems is an another technique that provides various benefits and widely used in laboratories as it is a physical process, which does not uses regenerating chemicals and hence, provides excellent defense against viruses, pyrogens, and bacteria making reverse osmosis systems cost-effective technique. Technological advancements in filtration products have resulted in an increase in the adoption rate, which in turn is expected to result in growth of the laboratory filtration in healthcare market.

Increasing focus towards the development of biopharmaceutical molecules and the rising application of filtration techniques are expected to contribute for the growth of the laboratory filtration in healthcare market

Companies are developing advance products for the treatment of various diseases and to develop this molecules wide range of laboratory filters are used in clinical and research institutes, which are expected to increase the demand for laboratory filtration. For instance, Ultrafiltration (UF) are widely used for the removal of suspended solids like bacteria, high-molecular-weight molecules, and endotoxin. The robust ultrafiltration processes plays crucial role in the development of bio-pharmaceutical products. Cellulose nitrate membrane filters are prepared by the reaction of nitric acid and cellulose. This filters are widely used for the filtration of peptides and proteins in molecular biology. Thus, increasing use of filtration technique in research and development of molecules is expected to support the growth of the laboratory filtration in healthcare market.

The key players operating in the global laboratory filtration in healthcare market include Merck Millipore, 3M Purification, Inc., Thermo Fisher Scientific, Inc., Sigma-Aldrich, Pall Corporation, Cantel Medical Corp, Sartorius Group, Macherey-Nagel Gmbh & Co., and GE Healthcare.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.